Home
JANX
JANX News

Latest Janux Therapeutics Inc. (JANX) News on July 26, 2024

Janux Therapeutics Announces Updates to Board of Directors

Business Wire

4 days ago

Janux Therapeutics Announces Updates to Board of Directors

TruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors

Barrons.com

a month ago

TruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

2 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

2 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

2 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

2 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

2 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

2 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

2 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 06/06/2024

MT Newswires

2 months ago

Janux Therapeutics Insider Sold Shares Worth $45,043,975, According to a Recent SEC Filing

MT Newswires

2 months ago

Janux Therapeutics Insider Sold Shares Worth $82,125,000, According to a Recent SEC Filing

MT Newswires

2 months ago

Scotiabank Starts Janux Therapeutics With Sector Perform Rating

We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate

Simply Wall St.

3 months ago

We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate

MT Newswires

3 months ago

Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating

Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates

GuruFocus.com

3 months ago

Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates

Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Business Wire

3 months ago

Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength

Zacks

3 months ago

Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength

Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors

Zacks

3 months ago

Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors

Janux Therapeutics (JANX) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

3 months ago

Janux Therapeutics (JANX) is on the Move, Here's Why the Trend Could be Sustainable

Why Janux Therapeutics Stock Is Crushing It This Week

Motley Fool

3 months ago

Why Janux Therapeutics Stock Is Crushing It This Week

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?

Benzinga

3 months ago

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?

Wall Street Analysts Think Janux Therapeutics (JANX) Could Surge 40.3%: Read This Before Placing a Bet

Zacks

3 months ago

Wall Street Analysts Think Janux Therapeutics (JANX) Could Surge 40.3%: Read This Before Placing a Bet

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options

Investor's Business Daily

3 months ago

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options

Why Janux Therapeutics Stock Soared as the Market Sagged Today

Motley Fool

4 months ago

Why Janux Therapeutics Stock Soared as the Market Sagged Today

After Plunging -11.78% in 4 Weeks, Here's Why the Trend Might Reverse for Janux Therapeutics (JANX)

Zacks

4 months ago

After Plunging -11.78% in 4 Weeks, Here's Why the Trend Might Reverse for Janux Therapeutics (JANX)

Janux Therapeutics (JANX) Upgraded to Buy: Here's What You Should Know

Zacks

4 months ago

Janux Therapeutics (JANX) Upgraded to Buy: Here's What You Should Know

Wall Street Analysts Believe Janux Therapeutics (JANX) Could Rally 57.47%: Here's is How to Trade

Zacks

4 months ago

Wall Street Analysts Believe Janux Therapeutics (JANX) Could Rally 57.47%: Here's is How to Trade

Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst

Benzinga

4 months ago

Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst

2 Stocks That Have More Than Tripled This Year: Are They Buys?

Motley Fool

4 months ago

2 Stocks That Have More Than Tripled This Year: Are They Buys?

GuruFocus.com

5 months ago

Janux Therapeutics Inc (JANX) Reports Encouraging Clinical Data and Solid Financial Position ...

Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Business Wire

5 months ago

Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

The Zacks Analyst Blog Highlights Janux Therapeutics, SoundHound, Root, Equillium and CleanSpark

Zacks

5 months ago

The Zacks Analyst Blog Highlights Janux Therapeutics, SoundHound, Root, Equillium and CleanSpark

After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy?

Motley Fool

5 months ago

After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy?

5 Stocks That More Than Doubled in February

Zacks

5 months ago

5 Stocks That More Than Doubled in February

Recent Price Trend in Janux Therapeutics, Inc. (JANX) is Your Friend, Here's Why

Zacks

5 months ago

Recent Price Trend in Janux Therapeutics, Inc. (JANX) is Your Friend, Here's Why

Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Business Wire

5 months ago

Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Janux Therapeutics Announces Proposed Public Offering of Common Stock

Business Wire

5 months ago

Janux Therapeutics Announces Proposed Public Offering of Common Stock

Janux Stock Launches 230% On Its 'Significant Opportunity' In Prostate Cancer Treatment

Investor's Business Daily

5 months ago

Janux Stock Launches 230% On Its 'Significant Opportunity' In Prostate Cancer Treatment

Janux shares triple on early cancer immunotherapy data

BioPharma Dive

5 months ago

Janux shares triple on early cancer immunotherapy data

Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors

Business Wire

5 months ago

Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors

Janux Therapeutics, Inc. (JANX) Moves 5.6% Higher: Will This Strength Last?

Zacks

5 months ago

Janux Therapeutics, Inc. (JANX) Moves 5.6% Higher: Will This Strength Last?

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008

Business Wire

5 months ago

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008

Inovio (INO) Moves 17.4% Higher: Will This Strength Last?

Zacks

5 months ago

Inovio (INO) Moves 17.4% Higher: Will This Strength Last?

13 Best Aerospace Stocks To Buy On Sale

Insider Monkey

6 months ago

13 Best Aerospace Stocks To Buy On Sale

CENTERSPACE APPOINTS OLA OYINSAN HIXON TO BOARD OF TRUSTEES

PR Newswire

6 months ago

CENTERSPACE APPOINTS OLA OYINSAN HIXON TO BOARD OF TRUSTEES

Independent Bank Corporation Reports 2023 Fourth Quarter Results

GlobeNewswire

6 months ago

Independent Bank Corporation Reports 2023 Fourth Quarter Results

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 01/25/2024

Are Robust Financials Driving The Recent Rally In Precision Drilling Corporation's (TSE:PD) Stock?

Simply Wall St.

6 months ago

Are Robust Financials Driving The Recent Rally In Precision Drilling Corporation's (TSE:PD) Stock?

Zacks Industry Outlook Highlights Frontier Communications and Weave Communications

Zacks

6 months ago

Zacks Industry Outlook Highlights Frontier Communications and Weave Communications

Bristow Enters Into New Long-term Equipment Financing for up to £55 Million

PR Newswire

6 months ago

Bristow Enters Into New Long-term Equipment Financing for up to £55 Million

Hepsiburada Announces Changes to its Board of Directors

GlobeNewswire

6 months ago

Hepsiburada Announces Changes to its Board of Directors

Ducommun, the Los Angeles Chargers and University of California, Irvine Mark Sixth Anniversary of STEM on the SidelinesTM Initiative Promoting Science, Technology, Engineering and Mathematics Among Southern California High Schools

GlobeNewswire

6 months ago

Ducommun, the Los Angeles Chargers and University of California, Irvine Mark Sixth Anniversary of STEM on the SidelinesTM Initiative Promoting Science, Technology, Engineering and Mathematics Among Southern California High Schools

Eaton Vance Tax-mangd Glo Buy-write Oppo's Dividend Analysis

GuruFocus.com

6 months ago

Eaton Vance Tax-mangd Glo Buy-write Oppo's Dividend Analysis

Wall Street Analysts Think Marinus Pharmaceuticals (MRNS) Could Surge 113.01%: Read This Before Placing a Bet

Zacks

6 months ago

Wall Street Analysts Think Marinus Pharmaceuticals (MRNS) Could Surge 113.01%: Read This Before Placing a Bet

Karat Packaging's (NASDAQ:KRT) Returns On Capital Are Heading Higher

Simply Wall St.

6 months ago

Karat Packaging's (NASDAQ:KRT) Returns On Capital Are Heading Higher

Weave Communications, Inc. (WEAV) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

6 months ago

Weave Communications, Inc. (WEAV) Stock Slides as Market Rises: Facts to Know Before You Trade

Janux Therapeutics Promotes Co-Founder Tommy DiRaimondo, Ph.D. to Chief Scientific Officer

Business Wire

7 months ago

Janux Therapeutics Promotes Co-Founder Tommy DiRaimondo, Ph.D. to Chief Scientific Officer

Those who invested in W.W. Grainger (NYSE:GWW) five years ago are up 210%

Simply Wall St.

7 months ago

Those who invested in W.W. Grainger (NYSE:GWW) five years ago are up 210%

Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Portillo’s Inc. to Participate in the 2024 ICR Conference

GlobeNewswire

7 months ago

Portillo’s Inc. to Participate in the 2024 ICR Conference

GlobeNewswire

7 months ago

Guggenheim Investments Announces January 2024 Closed-End Fund Distributions

An Intrinsic Calculation For Janux Therapeutics, Inc. (NASDAQ:JANX) Suggests It's 44% Undervalued

Simply Wall St.

7 months ago

An Intrinsic Calculation For Janux Therapeutics, Inc. (NASDAQ:JANX) Suggests It's 44% Undervalued

Is Portillo's Inc. (NASDAQ:PTLO) Potentially Undervalued?

Simply Wall St.

7 months ago

Is Portillo's Inc. (NASDAQ:PTLO) Potentially Undervalued?

enCore Energy Announces Change of Chief Financial Officer

CNW Group

7 months ago

enCore Energy Announces Change of Chief Financial Officer

United Natural Foods Releases Better for All Environmental, Social, and Governance Report for Fiscal Year 2023

Business Wire

7 months ago

United Natural Foods Releases Better for All Environmental, Social, and Governance Report for Fiscal Year 2023

WEX Names Sachin Dhawan New Chief Technology Officer

Business Wire

7 months ago

WEX Names Sachin Dhawan New Chief Technology Officer

10 Airline Stocks Billionaires Are Piling Into

Insider Monkey

8 months ago

10 Airline Stocks Billionaires Are Piling Into

Nayax Appoints New Chief Information Officer

GlobeNewswire

8 months ago

Nayax Appoints New Chief Information Officer

GlobeNewswire

8 months ago

Guggenheim Investments Announces December 2023 Closed-End Fund Distributions

Does Janux Therapeutics, Inc. (JANX) Have the Potential to Rally 205.5% as Wall Street Analysts Expect?

Zacks

8 months ago

Does Janux Therapeutics, Inc. (JANX) Have the Potential to Rally 205.5% as Wall Street Analysts Expect?

PLP APPOINTS DENNIS F. MCKENNA AS CHIEF EXECUTIVE OFFICER, ROBERT G. RUHLMAN AS EXECUTIVE CHAIRMAN

PR Newswire

8 months ago

PLP APPOINTS DENNIS F. MCKENNA AS CHIEF EXECUTIVE OFFICER, ROBERT G. RUHLMAN AS EXECUTIVE CHAIRMAN

David Johnson Bought 16% More Shares In Zentalis Pharmaceuticals

Simply Wall St.

8 months ago

David Johnson Bought 16% More Shares In Zentalis Pharmaceuticals

i3 Verticals Inc (IIIV) Reports Strong Revenue and Adjusted EBITDA Growth in Q4 and Full Fiscal ...

GuruFocus.com

8 months ago

i3 Verticals Inc (IIIV) Reports Strong Revenue and Adjusted EBITDA Growth in Q4 and Full Fiscal ...

i3 Verticals Reports Fourth Quarter and Full Fiscal Year 2023 Financial Results

Business Wire

8 months ago

i3 Verticals Reports Fourth Quarter and Full Fiscal Year 2023 Financial Results

Wall Street Analysts See a 220.17% Upside in Janux Therapeutics, Inc. (JANX): Can the Stock Really Move This High?

Zacks

8 months ago

Wall Street Analysts See a 220.17% Upside in Janux Therapeutics, Inc. (JANX): Can the Stock Really Move This High?

Janux Therapeutics, Inc. (JANX) Loses -34.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

9 months ago

Janux Therapeutics, Inc. (JANX) Loses -34.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

MannKind (MNKD) Q3 2023 Earnings Call Transcript

Motley Fool

9 months ago

MannKind (MNKD) Q3 2023 Earnings Call Transcript

Janux Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights

Business Wire

9 months ago

Janux Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights

GlobeNewswire

9 months ago

Guggenheim Investments Announces November 2023 Closed-End Fund Distributions

ALX Oncology Announces November Investor Conference Participation

GlobeNewswire

9 months ago

ALX Oncology Announces November Investor Conference Participation

Share on Social Networks: